Q Therapeutics

About:

Q Therapeutics develops cell-based therapeutics which focuses on developing novel products to treat amyotrophic lateral sclerosis, etc.,

Website: http://www.qthera.com

Twitter/X: q_therapeutics

Top Investors: EPIC Ventures, Toucan Capital, Q management, University of Utah Endowment, Salt Lake Life Science Angels

Description:

Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.